U.S. markets open in 3 hours 52 minutes
  • S&P Futures

    4,078.50
    -2.75 (-0.07%)
     
  • Dow Futures

    34,547.00
    -52.00 (-0.15%)
     
  • Nasdaq Futures

    12,019.75
    -22.50 (-0.19%)
     
  • Russell 2000 Futures

    1,891.10
    +3.60 (+0.19%)
     
  • Crude Oil

    81.14
    +0.59 (+0.73%)
     
  • Gold

    1,792.90
    +33.00 (+1.88%)
     
  • Silver

    22.30
    +0.52 (+2.38%)
     
  • EUR/USD

    1.0435
    +0.0027 (+0.26%)
     
  • 10-Yr Bond

    3.7030
    0.0000 (0.00%)
     
  • Vix

    20.90
    -0.99 (-4.52%)
     
  • GBP/USD

    1.2138
    +0.0077 (+0.63%)
     
  • USD/JPY

    136.4890
    -1.5910 (-1.15%)
     
  • BTC-USD

    17,106.93
    +216.12 (+1.28%)
     
  • CMC Crypto 200

    405.27
    +4.58 (+1.14%)
     
  • FTSE 100

    7,579.90
    +6.85 (+0.09%)
     
  • Nikkei 225

    28,226.08
    +257.09 (+0.92%)
     

DocuSign (DOCU) to Report Q2 Earnings: What's in the Offing?

DocuSign, Inc. DOCU is scheduled to report its second-quarter fiscal 2023 results on Sep 8, after the bell.

The company has an impressive earnings surprise history. Its earnings surpassed the Zacks Consensus Estimate in two of the trailing four quarters, matched once and missed once, delivering an average surprise of 7.3%.

Expectations This Time Around

The Zacks Consensus Estimate for the to-be-reported quarter’s revenues is pegged at $602 million, indicating 17.6% year-over-year growth. The top line is expected to have been driven by growth in subscription revenues, benefiting from strong growth in customer base.

The consensus mark for non-GAAP earnings is pegged at 42 cents, suggesting a 10.6% fall from the year-ago quarter. Higher operating expenses are likely to have weighed on the bottom line in the quarter.

What Our Model Says

Our proven Zacks model does not conclusively predict an earnings beat for DocuSign this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold), increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

DocuSign has an Earnings ESP of -11.91% and carries a Zacks Rank #4 (Sell).

You can see the complete list of today’s Zacks #1 Rank stocks here.

DocuSign Price and EPS Surprise

DocuSign Price and EPS Surprise
DocuSign Price and EPS Surprise

DocuSign price-eps-surprise | DocuSign Quote

Recent Performances of Some Other Business Services Companies

Equifax EFX reported mixed second-quarter 2022 results, wherein earnings beat estimates but revenues missed the same.

EFX’s adjusted earnings of $2.09 per share beat the Zacks Consensus Estimate by 3% and improved 5.6% on a year-over-year basis. Revenues of $1.32 billion missed the consensus estimate marginally but improved 6.6% year over year.

IQVIA Holdings IQV reported solid second-quarter 2022 results, wherein its earnings and revenues surpassed the Zacks Consensus Estimate.

IQV’s adjusted earnings per share of $2.44 beat the consensus mark by 2.1% and improved 15% on a year-over-year basis. Total revenues of $3.54 billion outpaced the consensus estimate by 1.2% and increased 3% year over year.

Omnicom Group OMC reported impressive second-quarter 2022 results, wherein the company’s earnings and revenues surpassed the Zacks Consensus Estimate.

OMC’s earnings of $1.68 per share beat the consensus mark by 7.7% and increased 15.1% year over year, driven by a strong margin performance. Total revenues of $3.6 billion surpassed the consensus estimate by 4.4% but declined slightly year over year.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Omnicom Group Inc. (OMC) : Free Stock Analysis Report
 
Equifax, Inc. (EFX) : Free Stock Analysis Report
 
IQVIA Holdings Inc. (IQV) : Free Stock Analysis Report
 
DocuSign (DOCU) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research